263 related articles for article (PubMed ID: 28848179)
21. Cerebral and corpus callosum atrophy in systemic lupus erythematosus.
Appenzeller S; Rondina JM; Li LM; Costallat LT; Cendes F
Arthritis Rheum; 2005 Sep; 52(9):2783-9. PubMed ID: 16142703
[TBL] [Abstract][Full Text] [Related]
22. Abnormality in hippocampal signal intensity predicts atrophy in patients with systemic lupus erythematosus.
Lapa AT; Pedro T; Francischinelli J; Coan AC; Costallat LT; Cendes F; Appenzeller S
Lupus; 2017 May; 26(6):633-639. PubMed ID: 27879427
[TBL] [Abstract][Full Text] [Related]
23. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin.
Katsumata Y; Harigai M; Kawaguchi Y; Fukasawa C; Soejima M; Takagi K; Tanaka M; Ichida H; Tochimoto A; Kanno T; Nishimura K; Kamatani N; Hara M
J Rheumatol; 2007 Oct; 34(10):2010-7. PubMed ID: 17896804
[TBL] [Abstract][Full Text] [Related]
25. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory profile in cerebrospinal fluid of patients with headache as a manifestation of neuropsychiatric systemic lupus erythematosus.
Fragoso-Loyo H; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
Rheumatology (Oxford); 2013 Dec; 52(12):2218-22. PubMed ID: 24026247
[TBL] [Abstract][Full Text] [Related]
27. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
28. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance volumetry of pathological brain foci in patients with systemic lupus erythematosus.
Podrazilová L; Peterová V; Olejárová M; Tegzová D; Krásenský J; Seidl Z; Kozelek P; Dostál C
Clin Exp Rheumatol; 2008; 26(4):604-10. PubMed ID: 18799091
[TBL] [Abstract][Full Text] [Related]
30. [A central nervous system lupus showing peculiar findings on cranial magnetic resonance imaging (MRI)].
Takahashi T; Kokubun Y; Okuhata Y; Sawada S; Mizutani T
Rinsho Shinkeigaku; 2003 Jul; 43(7):409-16. PubMed ID: 14582367
[TBL] [Abstract][Full Text] [Related]
31. Neuropsychiatric systemic lupus erythematosus: association with global disease activity.
Morrison E; Carpentier S; Shaw E; Doucette S; Hanly JG
Lupus; 2014 Apr; 23(4):370-7. PubMed ID: 24457602
[TBL] [Abstract][Full Text] [Related]
32. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
Fang H; Lan L; Qu Y; Zhang Q; Lv J
J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
[TBL] [Abstract][Full Text] [Related]
33. Smoking associates with increased BAFF and decreased interferon-γ levels in patients with systemic lupus erythematosus.
Raymond WD; Hamdorf M; Furfaro M; Eilertsen GO; Nossent JC
Lupus Sci Med; 2021 Oct; 8(1):. PubMed ID: 34725185
[TBL] [Abstract][Full Text] [Related]
34. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.
Horwitz DA; Gray JD; Behrendsen SC; Kubin M; Rengaraju M; Ohtsuka K; Trinchieri G
Arthritis Rheum; 1998 May; 41(5):838-44. PubMed ID: 9588735
[TBL] [Abstract][Full Text] [Related]
35. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
36. Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases.
Ichinose K; Arima K; Ushigusa T; Nishino A; Nakashima Y; Suzuki T; Horai Y; Nakajima H; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Motomura M; Kawakami A
Clin Immunol; 2015 Apr; 157(2):114-20. PubMed ID: 25656641
[TBL] [Abstract][Full Text] [Related]
37. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
38. Multimodal imaging in systemic lupus erythematosus patients with diffuse neuropsychiatric involvement.
Zivadinov R; Shucard JL; Hussein S; Durfee J; Cox JL; Bergsland N; Dwyer MG; Benedict RH; Ambrus J; Shucard DW
Lupus; 2013 Jun; 22(7):675-83. PubMed ID: 23640981
[TBL] [Abstract][Full Text] [Related]
39. A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.
Ercan E; Ingo C; Tritanon O; Magro-Checa C; Smith A; Smith S; Huizinga T; van Buchem MA; Ronen I
Neuroimage Clin; 2015; 8():337-44. PubMed ID: 26106559
[TBL] [Abstract][Full Text] [Related]
40. Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus.
Petri M; Naqibuddin M; Carson KA; Wallace DJ; Weisman MH; Holliday SL; Sampedro M; Narayana S; Fox PT; Franklin C; Padilla PA; Brey RL
J Rheumatol; 2008 Dec; 35(12):2348-54. PubMed ID: 18793003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
